Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC003811-23
Application #
6163256
Study Section
Surgery (SURG)
Project Start
Project End
Budget Start
Budget End
Support Year
23
Fiscal Year
1997
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Turcotte, Simon; Gros, Alena; Tran, Eric et al. (2014) Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res 20:331-43
Chinnasamy, Dhanalakshmi; Tran, Eric; Yu, Zhiya et al. (2013) Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice. Cancer Res 73:3371-80
Turcotte, Simon; Gros, Alena; Hogan, Katherine et al. (2013) Phenotype and Function of T Cells Infiltrating Visceral Metastases from Gastrointestinal Cancers and Melanoma: Implications for Adoptive Cell Transfer Therapy. J Immunol :
Turcotte, Simon; Rosenberg, Steven A (2011) Immunotherapy for metastatic solid cancers. Adv Surg 45:341-60
Davis, Jeremy L; Ripley, R Taylor; Frankel, Timothy L et al. (2010) Paraneoplastic granulocytosis in metastatic melanoma. Melanoma Res 20:326-9
Shrimali, Rajeev K; Yu, Zhiya; Theoret, Marc R et al. (2010) Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res 70:6171-80
Klapper, Jacob A; Thomasian, Armen A; Smith, Douglas M et al. (2009) Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy. J Immunol Methods 345:90-9
Parkhurst, Maria R; Joo, Jayne; Riley, John P et al. (2009) Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells. Clin Cancer Res 15:169-80
Wargo, Jennifer A; Robbins, Paul F; Li, Yong et al. (2009) Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression. Cancer Immunol Immunother 58:383-94
Peng, P D; Cohen, C J; Yang, S et al. (2009) Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. Gene Ther 16:1042-9

Showing the most recent 10 out of 127 publications